Recombinant MAP2K5 antibody
Quick Overview for Recombinant MAP2K5 antibody (ABIN7828398)
Target
See all MAP2K5 AntibodiesAntibody Type
Reactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Purpose
- Recombinant MEK5 Monoclonal Antibody
-
Purification
- Protein A purified
-
Immunogen
- Recombinant human MEK5 fragment
-
Isotype
- IgG, kappa
-
-
-
-
Application Notes
- WB 1:1000
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1 mg/mL
-
Buffer
- PBS, 50 % glycerol, 0.05 % Proclin 300, 0.05 % protein protectant.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles.
-
Expiry Date
- 12 months
-
-
- MAP2K5 (Mitogen-Activated Protein Kinase Kinase 5 (MAP2K5))
-
Alternative Name
- MEK5
-
Background
- MEK,MKK,MAP2K,MAPKK,PRKMK,MAP2K5,HsT17454,MAPKK5,MEK5,PRKMK5,MKK5,Dual specificity mitogen activated protein kinase kinase 5,Dual specificity mitogen-activated protein kinase kinase 5,EC 2.7.12.2,kinase 5,MAP kinase kinase 5,MAP kinase kinase MEK5b,MAPK/ERK kinase 5,MAPKK 5,MEK 5,mitogen-activated,mitogen-activated protein kinase kinase 5,MP2K5,Protein kinase,SAPKK5,SKK5,MEK5 is a dual specific kinase that specifically activates ERK5 involved in the regulation of diverse cellular processes, including cell growth, survival, and differentiation. The MEK5-ERK5 pathway is activated in numerous cancer types and plays a role in tumor growth and metastasis. Pharmacological targeting of the MEK5-ERK5 pathway has been investigated as a strategy for cancer treatment. MEK5 is activated by a variety of stimuli, including growth factors, cytokines, and oxidative stress. Activation of MEK5 is triggered by upstream kinases MEKK2 and MEKK3, leading to phosphorylation of MEK5 at Ser311 and Thr315, which subsequently leads to MEK5 dependent phosphorylation of EKR5 at Thr218 and Tyr220. Phosphorylation of ERK5 leads to nuclear translocation and regulation of several oncogenic transcription factors, including MEF2C, c-Fos, c-Myc, and Sap1. Cat.No. Product Name Clone No. IF:{{item.impact}} Journal:{{item.journal}} ({{item.year}}) DOI:{{item.doi}} Reactivity:{{item.species}} Sample Type:{{item.sample_type}} Previous {{ page }} Next Q{{(FAQpage.currentPage - 1)*pageSize+index+1}}:{{item.name}} Previous {{ page }} Next [
-
Molecular Weight
-
Calculated MW: 49, 50 kDa
Observed MW: 49, 50 kDa
-
UniProt
- Q13163
-
Pathways
- MAPK Signaling, Neurotrophin Signaling Pathway
Target
-